BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy flag Italy · Delayed Price · Currency is EUR
55.18
-1.28 (-2.27%)
At close: Mar 3, 2026

BridgeBio Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
502.08221.99.377.6569.72
Revenue Growth (YoY)
126.26%2285.27%-88.02%11.38%745.14%
Cost of Revenue
20.963.882.453.433.11
Gross Profit
481.11218.026.8674.2166.6
Selling, General & Admin
531.23288.93150.59143.19192.21
Research & Development
451.95506.46455.71399.46451.02
Other Operating Expenses
21.3515.617.9343.77-
Operating Income
-523.41-592.97-607.37-512.2-576.63
Interest Income
19.8517.2518.047.541.13
Interest Expense
-178.24-99.29-81.29-80.44-46.78
Other Non-Operating Income (Expense)
-50.71132.8217.37100.4535.82
Total Non-Operating Income (Expense)
-209.0950.78-45.8827.55-9.82
Pretax Income
-732.5-542.19-653.25-484.65-586.45
Provision for Income Taxes
0.441.15---
Net Income
-724.93-535.76-643.2-481.18-562.54
Minority Interest in Earnings
-8.01-7.59-10.05-3.47-23.92
Net Income to Common
-724.93-535.76-643.2-481.18-562.54
Shares Outstanding (Basic)
192186163147144
Shares Outstanding (Diluted)
192186163147144
Shares Change (YoY)
2.93%14.30%10.39%2.16%22.34%
EPS (Basic)
-3.78-2.88-3.95-3.26-3.90
EPS (Diluted)
-3.78-2.88-3.95-3.26-3.90
Free Cash Flow
-447.01-521.66-529.03-424.32-511.18
Free Cash Flow Per Share
-2.33-2.80-3.25-2.88-3.54
Gross Margin
95.82%98.25%73.71%95.58%95.53%
Operating Margin
-104.25%-267.22%-6528.75%-659.65%-827.12%
Profit Margin
-145.98%-244.86%-7021.94%-624.17%-841.20%
FCF Margin
-89.03%-235.09%-5686.62%-546.46%-733.23%
EBITDA
-517.98-586.9-600.88-505.43-570.79
EBITDA Margin
-103.17%-264.49%-6458.95%-650.93%-818.73%
EBIT
-523.41-592.97-607.37-512.2-576.63
EBIT Margin
-104.25%-267.22%-6528.75%-659.65%-827.12%
Effective Tax Rate
-0.06%-0.21%0.00%0.00%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.